The Effect of Byetta and Symlin on Post-meal Meal Blood Sugar Levels in Children With Type 2 Diabetes

NCT00950677 · Completed

Last updated 2026-05-28

This clinical trial tested how Byetta and Symlin affect blood sugar levels after meals in children who have type 2 diabetes.

Status Completed The study has finished.

Phase Phase 4 Monitors a drug already on the market.

Type Interventional (clinical trial)

Design Randomized, single-blind treatment study

Participants 16 people

Who can join Ages 12–21 · all sexes

Timeline Started 2009-07 · est. completion 2011-05

Where 1 site · United States

What this study is testing ClinicalTrials.gov NCT00950677 ↗

Description as written by the study sponsor.

The purpose of this study is to see if giving study drugs before a meal may lower blood sugars after the meal. An improvement in blood sugar control may prevent long-term problems of diabetes.

Treatments tested

Byetta (exenatide) Drug

exenatide 5 mcg subcutaneously
Symlin (pramlintide) Drug

pramlintide 60 mcg subcutaneously

Main thing measured	Glucose
Sponsor	Baylor College of Medicine
Conditions studied	Type 2 Diabetes
GLP-1 drugs	exenatide

Full protocol, eligibility, and contacts on ClinicalTrials.gov NCT00950677 ↗